Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prismocitrate 18 in CRRT
NCT02860130Phase 3Terminated
- Sponsor
- Vanttive
- Start
- Sep 2016
- Primary completion
- May 2018
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of prismocitrate 18 in acute kidney injury (AKI), sponsored by Vanttive. Started Sep 2016; status: terminated.
02
Drugs
prismocitrate 18
03
Conditions
acute kidney injury (AKI)
Beyond the preview
Go deeper on NCT02860130.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02860130.